/IDGXF
IDGXF Stock - Integrated Diagnostics Holdings plc
Healthcare|Medical - Diagnostics & ResearchOTC
$0.68-2.62%
$0.02 (-2.62%) • Dec 19
80
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
High Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.100
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.75
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for IDGXF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.67 – $0.69
TARGET (TP)$0.78
STOP LOSS$0.63
RISK/REWARD1:2.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.39
52W High$0.70
52W Low$0.28
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $5.72B | $4.12B | $3.61B | $5.22B | $2.66B |
| Gross Profit | $2.18B | $1.52B | $1.46B | $2.80B | $1.34B |
| Gross Margin | 38.1% | 37.0% | 40.6% | 53.7% | 50.5% |
| Operating Income | $1.21B | $737.76M | $832.19M | $2.26B | $985.55M |
| Net Income | $1.08B | $510.30M | $541.11M | $1.41B | $594.01M |
| Net Margin | 18.8% | 12.4% | 15.0% | 27.0% | 22.4% |
| EPS | $1.82 | $0.85 | $0.90 | $2.35 | $0.99 |
Company Overview
Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 2,000 diagnostic test services, including immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. The company operates in Egypt, Jordan, Sudan, and Nigeria. As of December 30, 2021, it operated a network of 452 branch labs. The company was founded in 1979 and is headquartered in Saint Helier, Jersey.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
IDGXFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.00
Q3 2024
EPS Surprise History
Q4 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | May 28, 2025 | — | — | — | — |
Q1 2025 | Mar 28, 2025 | — | — | — | — |
Q4 2024 | Nov 14, 2024 | — | — | — | — |
Q3 2024 | Aug 28, 2024 | — | $0.00 | — | — |
Q2 2024 | May 30, 2024 | — | $0.01 | — | — |
Q1 2024 | Mar 28, 2024 | — | $0.01 | — | — |
Q3 2023 | Sep 29, 2023 | — | $0.01 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.00 | — | — |
Q1 2023 | Mar 31, 2023 | — | $0.01 | — | — |
Q4 2022 | Dec 31, 2022 | — | $0.01 | — | — |
Q4 2022 | Nov 17, 2022 | — | $-0.00 | — | — |
Q3 2022 | Sep 12, 2022 | — | $0.01 | — | — |
Q2 2022 | Jun 8, 2022 | — | $0.03 | — | — |
Q2 2022 | Apr 21, 2022 | — | $0.03 | — | — |
Q4 2021 | Nov 16, 2021 | — | $0.05 | — | — |
Q3 2021 | Sep 2, 2021 | — | $0.03 | — | — |
Q2 2021 | Jun 2, 2021 | — | $0.03 | — | — |
Q2 2021 | May 19, 2021 | — | $0.02 | — | — |
Q4 2020 | Nov 19, 2020 | — | $0.02 | — | — |
Q3 2020 | Sep 2, 2020 | — | $0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about IDGXF
What is IDGXF's current stock price?
Integrated Diagnostics Holdings plc (IDGXF) is currently trading at $0.68 per share. The stock has moved -2.62% today.
What is the analyst price target for IDGXF?
No analyst price targets are currently available for this stock.
What sector is Integrated Diagnostics Holdings plc in?
Integrated Diagnostics Holdings plc operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the OTC exchange.
What is IDGXF's market cap?
Integrated Diagnostics Holdings plc has a market capitalization of $0.40 billion, making it a small-cap company.
Does IDGXF pay dividends?
No, Integrated Diagnostics Holdings plc does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAPDN
Applied DNA Sciences, Inc.
$5.62
Mkt Cap: $0.0B
BDSX
Biodesix, Inc.
$6.69
Mkt Cap: $0.0B
BIAF
bioAffinity Technologies, Inc.
$1.24
Mkt Cap: $0.0B
BIAFW
bioAffinity Technologies, Inc.
$0.33
Mkt Cap: $0.0B
GENE
Genetic Technologies Limited
$0.77
Mkt Cap: $0.0B
GTH
Genetron Holdings Limited
$4.03
Mkt Cap: $0.1B
HTGM
HTG Molecular Diagnostics, Inc.
$0.48
Mkt Cap: $0.0B
IDXG
Interpace Biosciences, Inc.
$1.20
Mkt Cap: $0.0B
INBS
Intelligent Bio Solutions Inc.
$6.14
Mkt Cap: $0.0B
ISPC
iSpecimen Inc.
$0.37
Mkt Cap: $0.0B
Explore stocks similar to IDGXF for comparison